Paper published in a journal (Scientific congresses and symposiums)
Final results of NKTR-102, a topoisomerase I inhibitor-polymer conjugate, in patients (Pts) with pretreated metastatic breast cancer (MBC) demonstrating significant antitumor activity
Garcia, A; Awada, A; Chan, S et al.
2011In Journal of Clinical Oncology, 29 (supplement 27)
Peer Reviewed verified by ORBi
 

Files


Full Text
Nektar bis.pdf
Publisher postprint (44.1 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Oncology
Author, co-author :
Garcia, A
Awada, A;  Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
Chan, S
JERUSALEM, Guy  ;  Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale
Coleman, R.E.
Huizing, M.T.
Mehdi, A
O'Reilly, S.M.
Hamm, J.T.
Barrett-Lee, P.J.
Cocquyt, V
Sideras, K
Young, D.E.
Brown, M
Zhao, C
Hannah, A.L.
Leung, A.C.F.
Masuoka, L.K.
Perez, E.A.
More authors (9 more) Less
Language :
English
Title :
Final results of NKTR-102, a topoisomerase I inhibitor-polymer conjugate, in patients (Pts) with pretreated metastatic breast cancer (MBC) demonstrating significant antitumor activity
Publication date :
2011
Event name :
2011 Breast Cancer Symposium
Event organizer :
ASCO
Event place :
San Francisco, United States
Event date :
08 - 10 September 2011
Audience :
International
Journal title :
Journal of Clinical Oncology
ISSN :
0732-183X
eISSN :
1527-7755
Publisher :
American Society of Clinical Oncology, Alexandria, United States - Virginia
Volume :
29
Issue :
supplement 27
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 15 October 2013

Statistics


Number of views
67 (1 by ULiège)
Number of downloads
0 (0 by ULiège)

Bibliography


Similar publications



Contact ORBi